Compass Therapeutics, Inc. announced the dosing of the first patient in an Investigator Sponsored Trial (IST) at The University of Texas MD Anderson Cancer Center, evaluating tovecimig (CTX-009), a ...
Tovecimig (DLL4 x VEGF-A bispecific antibody) met the primary endpoint in the ongoing randomized Phase 2/3 Study in patients with biliary tract cancer (BTC). Achieved a 17.1% overall response rate ...
Leverage the Nasdaq+ Scorecard to analyze stocks based on your investment priorities and our market data.
Jeep teases the electric Compass for the first time (Source: Stellantis) It’s official: Jeep’s most globally available model is going electric. The Jeep Compass EV we’ve been waiting for is due out ...
Compass took a second quarter victory lap on Wednesday, reporting a profit for the first time as a publicly traded company and flipping the last period’s massive loss on its head. The company ...
Readers with a keen interest in the decades-long development of psychedelic-assisted therapy could be forgiven for thinking Christmas has come early. Less than a week after the first-ever request for ...
Q1 organic revenue growth 9.2% vs analyst forecast 8.8% FX could hit FY revenue by $558 million at current rates Annual outlook retained, shares fall 0.9% Feb 6 (Reuters) - Compass (CPG.L), opens new ...
The new EC-37B Compass Call is built from a Gulfstream G550 business jet, with electronic warfare systems created by BAE Systems. L3Harris conducted the integration work at its Waco, Texas, facility. ...
--Compass, Inc., the largest 1 tech-enabled real estate brokerage, announced its financial results for the first quarter ended March 31, 2023. "We had a strong first quarter of 2023 that was ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results